No segmentation disclosed for this filer. n/a
Tvardi Therapeutics, Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
No filings loaded — no CIK (non-SEC filer).